Российский кардиологический журнал (Jan 2022)

Antithrombotic therapy for atrial fibrillation and comorbidities — how to choose the optimal solution?

  • E V Schlyakhto,
  • E I Baranova,
  • V A Ionin

DOI
https://doi.org/10.15829/1560-4071-2021-4801
Journal volume & issue
Vol. 26, no. 12

Abstract

Read online

The review discusses the problem of anticoagulant therapy for the prevention of stroke and systemic embolism in patients with atrial fibrillation and comorbidities (hypertension, heart defects, including after heart valve surgery, coronary artery disease, diabetes mellitus, chronic kidney disease, gastrointestinal diseases, anemia, cancer), as well as with a high risk of emergency operations and injuries.

Keywords